UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 61

Sortiert nach

Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome

The New England journal of medicine, 2002-06, Vol.346 (24), p.1863-1870

2002

Volltextzugriff (PDF)

Genital Tract Human Immunodeficiency Virus Type 1 (HIV-1) Shedding and Inflammation and HIV-1 env Diversity in Perinatal HIV-1 Transmission

The Journal of infectious diseases, 2000-02, Vol.181 (2), p.555-563

2000

Volltextzugriff (PDF)

Treatment Interruption after Pregnancy: Effects on Disease Progression and Laboratory Findings

Infectious Diseases in Obstetrics and Gynecology, 2009, Vol.2009, p.456717-8

2009

Volltextzugriff (PDF)

Risk factors for in utero and intrapartum transmission of HIV

Journal of acquired immune deficiency syndromes (1999), 2005-01, Vol.38 (1), p.87

2005

Volltextzugriff (PDF)

Cell-Associated Genital Tract Virus and Vertical Transmission of Human Immunodeficiency Virus Type 1 in Antiretroviral-Experienced Women

The Journal of infectious diseases, 2003-02, Vol.187 (3), p.375-384

2003

Volltextzugriff (PDF)

Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission

AIDS research and human retroviruses, 1998-04, Vol.14 Suppl 1 (suppl. 1), p.S43-S49

1998

Volltextzugriff (PDF)

Transmission of Human Immunodeficiency Virus Infection Presumed to Have Occurred via Female Homosexual Contact

Clinical infectious diseases, 1993-12, Vol.17 (6), p.1003-1005

1993

Volltextzugriff (PDF)

Low risk of post-cesarean section infection in insulin-requiring diabetic women

Diabetes care, 1996-06, Vol.19 (6), p.597

1996

Volltextzugriff (PDF)

Quantitative Microbiologic Models for Preterm Delivery

Journal of Clinical Microbiology, 2003-03, Vol.41 (3), p.1073-1079

2003

Volltextzugriff (PDF)

Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy

Journal of acquired immune deficiency syndromes (1999), 2005-04, Vol.38 (4), p.449

2005

Volltextzugriff (PDF)

Adherence to antiretrovirals among US women during and after pregnancy

Journal of acquired immune deficiency syndromes (1999), 2008-08, Vol.48 (4), p.408

2008

Volltextzugriff (PDF)

No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms

American journal of obstetrics and gynecology, 2001-10, Vol.185 (4), p.854-858

2001

Volltextzugriff (PDF)

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy

AIDS (London), 2010-01, Vol.24 (1), p.45-53

2010

Volltextzugriff (PDF)

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

AIDS (London), 2009-11, Vol.23 (18), p.2425-2430

2009

Volltextzugriff (PDF)

Mode of delivery and postpartum HIV-1 disease progression : The women and infants transmission study

AIDS (London), 2006-02, Vol.20 (3), p.429-436

2006

Volltextzugriff (PDF)

The Effect of Cigarette Smoking, Chlamydia trachomatis Infection, and Vaginal Douching on Ectopic Pregnancy

Obstetrics and gynecology (New York. 1953), 1992-01, Vol.79 (1), p.85-90

1992

Volltextzugriff (PDF)

Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus–infected women

Obstetrics and gynecology (New York. 1953), 2001-02, Vol.97 (2), p.161-168

2001

Volltextzugriff (PDF)

Risk factors for preterm premature rupture of fetal membranes: A multicenter case-control study

American journal of obstetrics and gynecology, 1990-07, Vol.163 (1), p.130-137

1990

Volltextzugriff (PDF)

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals

AIDS (London), 2010-01, Vol.24 (1), p.109-114

2010

Volltextzugriff (PDF)

Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation

Obstetrics and gynecology (New York. 1953), 1989-06, Vol.73 (6), p.921-927

1989

Volltextzugriff (PDF)

Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women

Obstetrics and gynecology (New York. 1953), 1997-06, Vol.89 (6), p.967-974

1997

Volltextzugriff (PDF)

High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998-2004

AIDS (London), 2007-10, Vol.21 (15), p.2103-2106

2007

Volltextzugriff (PDF)

Protease Inhibitor Use During Pregnancy: Is There an Obstetrical Risk?

The Journal of infectious diseases, 2006-05, Vol.193 (9), p.1191-1194

2006

Volltextzugriff (PDF)

A disproportionate increase in IL-1β over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth

American journal of obstetrics and gynecology, 2004-05, Vol.190 (5), p.1191-1197

2004

Volltextzugriff (PDF)

Prevention of transmission. Pharmaceutical and obstetric approaches

Obstetrics and gynecology clinics of North America, 1997-12, Vol.24 (4), p.785-795

Tuomala, R E

1997

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(57)
Mit Volltextzugriff
(43)

Publikationsform

Artikel
(60)
Tagungsberichte
(1)

Sprache

Englisch
(61)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Antiretroviral Therapy during Pregnancy and the Risk of an Adverse Outcome

Genital Tract Human Immunodeficiency Virus Type 1 (HIV-1) Shedding and Inflammation and HIV-1 env Diversity in Perinatal HIV-1 Transmission

Treatment Interruption after Pregnancy: Effects on Disease Progression and Laboratory Findings

Risk factors for in utero and intrapartum transmission of HIV

Cell-Associated Genital Tract Virus and Vertical Transmission of Human Immunodeficiency Virus Type 1 in Antiretroviral-Experienced Women

Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission

Transmission of Human Immunodeficiency Virus Infection Presumed to Have Occurred via Female Homosexual Contact

Low risk of post-cesarean section infection in insulin-requiring diabetic women

Quantitative Microbiologic Models for Preterm Delivery

Improved obstetric outcomes and few maternal toxicities are associated with antiretroviral therapy, including highly active antiretroviral therapy during pregnancy

Adherence to antiretrovirals among US women during and after pregnancy

No increase in rates of early-onset neonatal sepsis by non-group B Streptococcus or ampicillin-resistant organisms

Postpartum antiretroviral drug resistance in HIV-1-infected women receiving pregnancy-limited antiretroviral therapy

Increased risk of hepatotoxicity in HIV-infected pregnant women receiving antiretroviral therapy independent of nevirapine exposure

Mode of delivery and postpartum HIV-1 disease progression : The women and infants transmission study

The Effect of Cigarette Smoking, Chlamydia trachomatis Infection, and Vaginal Douching on Ectopic Pregnancy

Cost-effectiveness of elective cesarean delivery in human immunodeficiency virus–infected women

Risk factors for preterm premature rupture of fetal membranes: A multicenter case-control study

Lack of increased hepatotoxicity in HIV-infected pregnant women receiving nevirapine compared with other antiretrovirals

Pregnancy outcome after premature rupture of the membranes at or before 26 weeks' gestation

Changes in total, CD4+, and CD8+ lymphocytes during pregnancy and 1 year postpartum in human immunodeficiency virus-infected women

High prevalence of primary lamivudine and nelfinavir resistance in HIV-1-infected pregnant women in the United States, 1998-2004

Protease Inhibitor Use During Pregnancy: Is There an Obstetrical Risk?

A disproportionate increase in IL-1β over IL-1ra in the cervicovaginal secretions of pregnant women with altered vaginal microflora correlates with preterm birth

Prevention of transmission. Pharmaceutical and obstetric approaches

Suchergebnisse filtern